Alnylam Pharmaceuticals
ALNY
#601
Rank
NZ$57.89 B
Marketcap
$447.35
Share price
-5.28%
Change (1 day)
73.67%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company